Clinical Trials Browser

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) × apalutamide × Clear all

NCT05649943 2025-09-03

APPROACH

Phase NA Recruiting

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)